BALLAST ADVISORS LLC

Position in LLY — ELI LILLY & Co

CIK 1803415 WOODBURY, MN

Position in LLY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$542,142

+$126,406 QoQ

Shares Held

452

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#3,688

of 4,605 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 56% Shared 0% None 44%

Healthcare · as of Jun 30, 2026

BALLAST ADVISORS LLC holds $3,717,424 across 6 Drug Manufacturers - General names. LLY ranks #3 (14.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	3,791	$962,800
2	NVO	Novo Nordisk A S	19,653	$942,164
3	LLY	ELI LILLY & Co This page	452	$542,142
4	ABBV	AbbVie Inc.	2,140	$538,509
5	AMGN	Amgen Inc	1,297	$469,669
6	MRK	Merck & Co., Inc.	2,040	$262,140

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$542,142	452	0.0%	Shares	Sole	2026-08-12
2026-03-31	$415,736	452	-0.4%	Shares	Sole	2026-05-13
2025-12-31	$487,904	454	-4.2%	Shares	Sole	2026-02-03
2025-09-30	$361,662	474	+4.9%	Shares	Sole	2025-11-12
2025-06-30	$352,347	452	-0.4%	Shares	Sole	2025-07-31
2025-03-31	$374,963	454	0.0%	Shares	Sole	2025-05-07
2024-12-31	$350,488	454	+0.4%	Shares	Sole	2025-02-11
2024-09-30	$400,444	452	0.0%	Shares	Sole	2024-10-30
2024-06-30	$409,231	452	-0.2%	Shares	Sole	2024-07-26
2024-03-31	$352,415	453	+0.2%	Shares	Sole	2024-05-01
2023-12-31	$263,479	452	-22.7%	Shares	Sole	2024-01-30
2023-09-30	$314,221	585	0.0%	Shares	Sole	2023-10-19
2023-06-30	$274,353	585	-25.5%	Shares	Sole	2023-08-04
2023-03-31	$269,584	785	0.0%	Shares	Sole	2023-05-09
2022-12-31	$287,184	785	-13.3%	Shares	Sole	2023-01-26
2022-09-30	$292,631	905	-1.6%	Shares	Sole	2022-11-14
2022-06-30	$298,291	920	0.0%	Shares	Sole	2022-07-20
2022-03-31	$263,460	920	0.0%	Shares	Sole	2022-04-21
2021-12-31	$254,122	920	—	Shares	Sole	2022-02-04
No filing history on record for this holder in this stock.